David M. Knott’s Bristol-Myers Squibb BMY Stock Holding History

David M. Knott’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.51M	Sell	42,409 -1,000	-2%	-$65.9K	0.91%	31
2021 Q2	$2.9M	Sell	43,409 -8,000	-16%	-$522K	1.03%	27
2021 Q1	$3.25M	Sell	51,409 -1,000	-2%	-$62.2K	1.39%	20
2020 Q4	$3.25M	Buy	52,409 +6,000	+13%	+$369K	1.47%	19
2020 Q3	$2.8M	Hold	46,409	–	–	1.64%	15
2020 Q2	$2.73M	Buy	46,409 +500	+1%	+$29.9K	1.49%	16
2020 Q1	$2.56M	Buy	45,909 +2,194	+5%	+$134K	1.62%	14
2019 Q4	$2.81M	Buy	43,715 +13,847	+46%	+$793K	1.14%	21
2019 Q3	$1.51M	Buy	29,868 +2,788	+10%	+$131K	0.64%	31
2019 Q2	$1.23M	Buy	27,080 +21,652	+399%	+$1.01M	0.52%	33
2019 Q1	$259K	Buy	5,428 +3,203	+144%	+$160K	0.1%	72
2018 Q4	$116K	Hold	2,225	–	–	0.05%	76
2018 Q3	$138K	Hold	2,225	–	–	0.04%	83
2018 Q2	$123K	Hold	2,225	–	–	0.05%	90
2018 Q1	$141K	Hold	2,225	–	–	0.06%	81
2017 Q4	$136K	Hold	2,225	–	–	0.05%	85
2017 Q3	$142K	Buy	2,225 +403	+22%	+$23.5K	0.06%	79
2017 Q2	$102K	Buy	1,822 +100	+6%	+$5.44K	0.04%	74
2017 Q1	$94K	Buy	+1,722	New	+$94.4K	0.05%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

David M. Knott's BMY Position: Q3 2021 in Review

David M. Knott reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q3 2021, selling an estimated $65.9K and leaving 42,409 shares worth $2.51M. The position accounts for 0.91% of the portfolio, ranked #31.

David M. Knott first reported a position in BMY in Q1 2017 and has held it in 19 quarters since. The position peaked at $3.25M in Q4 2020. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

David M. Knott held 42,409 shares of Bristol-Myers Squibb worth $2.51M as of Q3 2021.
David M. Knott sold 1,000 Bristol-Myers Squibb shares in Q3 2021, an estimated $65.9K.
Bristol-Myers Squibb made up 0.91% of David M. Knott's portfolio in Q3 2021, its #31 holding.
David M. Knott first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 19 quarters since.
David M. Knott's Bristol-Myers Squibb position peaked at $3.25M in Q4 2020.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.